The College of American Pathologists (CAP), in collaboration with five other societies, developed a draft evidence-based clinical practice guideline that aims to optimize PD-L1 testing for patients with non-small cell lung cancer (NSCLC) who are being considered for immunooncology therapy.
The College of American Pathologists (CAP) earned reapproval from the Centers for Medicare & Medicaid Services (CMS) as an accreditation organization for clinical laboratories.
Recognizing a need for evidence-based recommendations to guide molecular testing in the management of patients with cancer, the College of American Pathologists (CAP) and three collaborating societies are developing a clinical guideline for testing DNA mismatch repair (MMR) and microsatellite instability (MSI) status in patients with a range of cancer types.
Elizabeth K. Usher, MBA, has been named executive director/chief executive officer of the American Academy of Dermatology and American Academy of Dermatology Association (AAD/A). Usher comes to the Academy from the College of American Pathologists (CAP), most recently holding the position of chief market and customer officer.
Pathologists are increasingly optimistic about the potential of the human microbiome to help guide diagnosis and monitoring of chronic diseases.
College of American Pathologists Inaugurates Patrick E. T. Godbey as President
The College of American Pathologists Releases List of Longest Accredited Laboratories in U.S. Northfield, IL (June 24, 2019) This week, the College of American Pathologists (CAP) released a list of its longest accredited laboratories in the United States. These 41…